Neuraxpharm Boosts Branded Business With Established Sanofi Portfolios

Latest Acquisition Should See Firm’s Annual Gross Sales Expand To €600m

 
• By Chloe Kent

CNS specialist Neuraxpharm has purchased two of Sanofi’s product portfolios, substantially expanding the number of branded products it has to offer.

Graphic depiction of central nervous system
Neuraxpharm has purchased two portfolios of CNS, pain and vascular disease products • Source: Shutterstock

More from Deals

More from Business